{
  "ticker": "HPC",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02969098",
  "id": "02969098",
  "pages": 3,
  "price_sensitive": false,
  "date": "20250714",
  "time": "1604",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06ls9zgtqh28zt.pdf",
  "summary": "- **Substantial Holder Notice**: David Hemming acquired a 5.74% stake in The Hydration Pharmaceuticals Company Limited (24,750,000 FPO shares) as of 11/07/2025.  \n- **Breakdown of Holdings**:  \n  - Syrax Investment Pty Ltd (associate) holds **19,000,000 FPO shares** (controlled by Hemming).  \n  - David Hemming directly holds **5,750,000 FPO shares**.  \n- **Recent Acquisitions**:  \n  - Syrax Investments purchased shares between 2/05/2025 and 10/07/2025, with **6,000,000 FPO shares acquired on 10/07/2025 for $60,000**.  \n  - Hemming\u2019s direct purchases include **1,750,000 FPO shares on 9/07/2025 for $17,500**.  \n\nNo other material trading or capital markets information identified.",
  "usage": {
    "prompt_tokens": 2021,
    "completion_tokens": 204,
    "total_tokens": 2225,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-14T06:17:32.717024"
}